Professor Peter Schmid
“With Liberty, Entia has developed a practical solution that addresses some of the biggest challenges we face in treating an increasing number of people with cancer. Our clinics are getting busier and implementing technologies like this would allow us to manage people more comfortably at home, improve their experience of care and potentially reduce the severity and occurrence of treatment side effects. Plus by improving clinic capacity we can streamline services to free up time for our clinical teams and plan treatments more efficiently. It’s an amazing approach.”
Chair of Cancer Medicine at Barts Cancer Institute:
Dr Sacha J Howell FRCP PhD
“Financial toxicity is a huge problem for cancer patients so having access to technology like Liberty that could remove the need for some hospital appointments offers real benefits. Working in breast cancer, many of my patients are young women with jobs and families, trying to keep life as normal as possible. I know that having one less appointment to attend makes a real difference to them, taking a lot of stress out of their lives and giving them back a little more time and money.”
“Partnering with digital health and monitoring experts such as Entia will further support Pfizer’s breakthrough therapies in an area where the burden of living with cancer is significant.”
Pfizer
“Partnering with digital health and monitoring experts such as Entia will further support Pfizer’s breakthrough therapies in an area where the burden of living with cancer is significant.”
“Partnering with digital health and monitoring experts such as Entia will further support Pfizer’s breakthrough therapies in an area where the burden of living with cancer is significant.”